We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
28/6/2021 10:00 | What matters is steadily improving results and positive updates on drug developments. Next update end of July. If the City become more confident on the strategy you end up with a company that's growing profitability ... more than making up for any loss in dividend. Many companies don't pay any dividends ... yet they don't trade at zero? Go figure. | alex1621 | |
28/6/2021 09:56 | montyhedge , do not panic as chart shows it is still in a short term uptrend and likely to reach 1450 again as minimum target in next few days hopefully . | arja | |
28/6/2021 09:06 | I'm hoping its going to be not just amateur hour but amateur six months. I quite fancy my amateur 1800. | netcurtains | |
28/6/2021 08:39 | Lol 30% dividend cut in 2022. Then again 2023 to 45p. You lot seem happy. First hour of trade on a Monday is amateur hour. MM just marked up on some PR in a Sunday newspaper. | montyhedge | |
28/6/2021 08:26 | PRESS: GSK hires Goldman and Citi for spinoff of Consumer HealthcareSource: Alliance NewsmithKline PLC has hired two investment banks to advise on plans to list its consumer unit next year and defend against the influence of activist Elliott.spud | spud | |
28/6/2021 06:44 | Hard work starts now for Glaxo, says Interactive Investor The hard work starts now for GlaxoSmithKline (GSK) after it confirmed the spin-off of its consumer healthcare business, says Interactive Investor. The group is planning to demerge 80% of its consumer healthcare division as part of a wide-ranging five-year plan that includes growing sales more than 5% and profit more than 10%. It also wants to deliver sales of over £33bn, prioritise research and development, and commercial investment in vaccines and specialty medicines under chief executive Emma Walmsley. Analyst Richard Hunter said the plans were ‘undeniably ambitious’ but it was not certain they would create an ‘inflection point’ for the shares. ‘Following a strategic reset, the hard work arguably starts here,’ he said. ‘AstraZeneca (AZN) is for the moment significantly preferred in terms of the market consensus, coming in at a strong ‘buy’. Glaxo, meanwhile, remains a ‘hold’ in terms of the general view and has much ground to make up to reverse the years of what has been a tepid share price performance.’ Shares in Glaxo edged up 0.2%, or 2.2p, to £14.13 on Friday. | grahamite2 | |
27/6/2021 22:39 | They end up as holders of both new companies | ayl30 | |
27/6/2021 22:05 | What happens to existing shareholders at aplit? | ifthecapfits | |
27/6/2021 21:26 | I can see interest here running up the split. | pander45 | |
27/6/2021 10:01 | Big positive article in Sunday Times on GLAXOs "fighting back lady". On balance looks good for share price. | netcurtains | |
26/6/2021 18:39 | This is 2011 news by BBC re Glaxo director taken to court | whatsup32 | |
26/6/2021 18:18 | J&J to stop selling Opioids and settles in New York State. Pays $230m They will stop manufacturing and distributing too. I’m currently not holding GSK , just relaying info as it may be relevant in some way to GSK | whatsup32 | |
25/6/2021 15:41 | There is no sense to it. You are saying this to someone who doesn't care who posts? | alex1621 | |
25/6/2021 15:27 | Just read what I said,there are no worms in it . | abdullla | |
25/6/2021 14:34 | Good luck trying to find something that doesn't exist. Did you get bored calling everything fake news so decided to make some of your own? | alex1621 | |
25/6/2021 14:31 | Can you show me a post where I've asked someone not to post? | alex1621 | |
25/6/2021 13:53 | What has no declarable stake and no seat on the board? Answer in 5 minutes, and 35, and 1hr, and 2 hr and 3 hr .... until he buys back when Elliot will be very influential and drive gsk to unimaginable profits once gain. ffs, ground hog day aint got nothing on monty. | pierre oreilly | |
25/6/2021 13:44 | There are posters here and other bulletin boards who are here to keep some of us and they themselves out of boredom,I feel they may or may not have any GSK shares or any other shares for that matter,let them stay here if they want to. | abdullla | |
25/6/2021 11:55 | He could not pay me enough. | montyhedge | |
25/6/2021 11:05 | With all the excitement now gone GSK share price will go up and down all day long,wheels on the bus................ | abdullla | |
25/6/2021 10:44 | I'm stunned that Paul Singer hasn't offered you a consultancy contract Monty. | alex1621 | |
25/6/2021 10:30 | If they did walk, 1325p. | montyhedge | |
25/6/2021 10:28 | Well, go on then, say goodbye! | eurofox | |
25/6/2021 10:25 | I reckon Elliott will throw in the towel, they had the dividend, nice profit, they can't do anything, no declarable stake, no seat on the board, I would say goodbye. | montyhedge | |
25/6/2021 10:07 | ZHO, good article and thanks for posting it . We might need some patience with GSK after the recent good run has stalled and now consolidating before moving higher hopefully ! | arja |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions